User:MDolinar: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Marko Dolinar== | ==Marko Dolinar== | ||
I am | I am at the [http://www.uni-lj.si/ University of Ljubljana] (Slovenia) [http://www.fkkt.uni-lj.si/en/ Faculty of Chemistry and Chemical Technology] Biochemistry Chair. Before joining the Faculty (in 2001), I was research associate at the [http://www.ijs.si/ijsw/JSI Jozef Stefan Institute] where my research was focused on cysteine proteinases (mainly cathepsins L, H). As part-timer at the JSI from 2001-2006, I continued my work on cathepsins but spent much of my time organizing research conferences on proteinases and their inhibitors. | ||
Currently, I am | Currently, I am involved in development of recombinant humanized antibodies against prion protein (this is a collaboration with the Blood Transfusion Centre of Slovenia) and in a molecular biotechnology project on properties of linkers in fusion proteins. In 2006 and 2007 I was co-supervisor of the Slovenian iGEM teams. We won the Grand Prize in 2006 [http://parts.mit.edu/wiki/index.php/Ljubljana%2C_Slovenia_2006] and were finalists and winners in the Medicine and Health track in 2007 [http://parts.mit.edu/igem07/index.php/Ljubljana]. My work on Synthetic biology continues with construction and testing of an array of versatile expression vectors based on the pSB series. | ||
Revision as of 04:55, 28 March 2008
Marko Dolinar
I am at the University of Ljubljana (Slovenia) Faculty of Chemistry and Chemical Technology Biochemistry Chair. Before joining the Faculty (in 2001), I was research associate at the Jozef Stefan Institute where my research was focused on cysteine proteinases (mainly cathepsins L, H). As part-timer at the JSI from 2001-2006, I continued my work on cathepsins but spent much of my time organizing research conferences on proteinases and their inhibitors.
Currently, I am involved in development of recombinant humanized antibodies against prion protein (this is a collaboration with the Blood Transfusion Centre of Slovenia) and in a molecular biotechnology project on properties of linkers in fusion proteins. In 2006 and 2007 I was co-supervisor of the Slovenian iGEM teams. We won the Grand Prize in 2006 [1] and were finalists and winners in the Medicine and Health track in 2007 [2]. My work on Synthetic biology continues with construction and testing of an array of versatile expression vectors based on the pSB series.
